NASDAQ: BOLT
Bolt Biotherapeutics Inc Stock Ownership - Who owns Bolt Biotherapeutics?

Insider buying vs selling

Have Bolt Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sarah NemecSenior VP Finance and PAO2025-12-05125$4.61
$575.88Buy
William P. QuinnPresident CEO and CFO2025-12-05125$4.61
$575.88Buy

1 of 1

BOLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BOLT insiders and whales buy or sell their stock.

BOLT Shareholders

What type of owners hold Bolt Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital VIII LLC305.54%5,885,846$18.70MInsider
Holdings A. Novo192.28%3,703,991$11.77MInsider
Edgar Engleman170.96%3,293,286$10.46MInsider
James Healy142.99%2,754,437$8.75MInsider
Sofinnova Venture Partners X LP142.99%2,754,437$8.75MInsider
Mahendra Shah75.18%1,448,286$4.60MInsider
Edith A. Perez2.42%46,612$148.09kInsider
Grant Yonehiro2.02%38,918$123.64kInsider
Randall C. Schatzman0.67%12,859$40.85kInsider
William P. Quinn0.12%2,313$7.35kInsider

1 of 3

BOLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLT0.00%100.00%Net Buying
CVKD0.00%28.17%Net SellingNet Selling
EVGN0.00%12.95%Net BuyingNet Buying
ENVB0.01%15.55%
BGMS0.00%100.00%Net Selling

Bolt Biotherapeutics Stock Ownership FAQ

Who owns Bolt Biotherapeutics?

Bolt Biotherapeutics (NASDAQ: BOLT) is owned by 0.03% institutional shareholders, 1,035.42% Bolt Biotherapeutics insiders, and 0.00% retail investors. Vivo Capital VIII LLC is the largest individual Bolt Biotherapeutics shareholder, owning 5.89M shares representing 305.54% of the company. Vivo Capital VIII LLC's Bolt Biotherapeutics shares are currently valued at $18.70M.

If you're new to stock investing, here's how to buy Bolt Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.